Piramal Pharma Solutions

Piramal Pharma Solutions PPS is a CDMO offering end-to-end development and manufacturing solutions across the drug lifecycle.

We serve our clients through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies, Commercial supply of APIs, and Finished dosage forms. We also offer specialized services like the development and manufacture of Highly Potent APIs and Antibody Drug Conjugation. Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide. For more information and updates, please visit: www.piramalpharmasolutions.com

Joining us at World ADC London | Booth #31 — meet Hubert LOCHARD, Director – Business Development. Hubert will be on-si...
02/06/2026

Joining us at World ADC London | Booth #31 — meet Hubert LOCHARD, Director – Business Development.

Hubert will be on-site to discuss how our comprehensive ADC platform supports customers across the entire lifecycle, including payload-linker development, bioconjugation, high-potency manufacturing, and sterile fill-finish.

Dayn Sommer, Ph.D. Conor Barry Nathan Richardson Frédéric Kahn Martina Callaghan

02/05/2026

Supporting ADC programs from early proof-of-concept and toxicology studies through to clinical and commercial supply, our Grangemouth facility has been a trusted centre for Antibody-Drug Conjugate (ADC) development and manufacturing for over two decades.​

With integrated capabilities across process development, analytical and bio-analytical services, scale-up, GMP manufacturing, and aseptic fill-finish, Grangemouth enables seamless progression at every stage.​

Additionally, dedicated GMP production suites, deep expertise in high-potency cytotoxic compounds, and a quality management system aligned to ICH Q7 ensure consistent, compliant delivery.​

Approved by leading global regulatory authorities including the US FDA and UK MHRA, the Grangemouth facility continues to advance high-quality bioconjugate solutions at scale.​

Want to learn more about ADC development at our Grangemouth site? Access the detailed factsheet through the link below.
https://www.piramalpharmasolutions.com/facilities/antibody-drug-conjugate-development-and-manufacturing-grangemouth

Catch our team of experts at WORLD ADC London​

🗓️23rd - 26th February, 2026​

Booth No.31
London, UK

Flying Across the Atlantic for Meaningful ADC Conversations!Dayn Sommer, Director, Business Development will be flying i...
02/04/2026

Flying Across the Atlantic for Meaningful ADC Conversations!

Dayn Sommer, Director, Business Development will be flying in from North America and joining us at Booth #31 at World ADC London.

Stop by to discuss how we support ADC programs with end-to-end solutions designed for speed, quality, and scale. Discover how our integrated ADC capabilities are helping partners accelerate development from discovery to commercial scale.

Booth 31 | World ADC London

Let’s talk ADCs!

Advancing patient-centric drug delivery! Piramal Pharma Solutions has successfully developed and commercialized Tablet-i...
02/03/2026

Advancing patient-centric drug delivery!

Piramal Pharma Solutions has successfully developed and commercialized Tablet-in-Capsule capabilities across our integrated drug product sites in Pithampur and Ahmedabad.

This achievement showcases the power of our integrated network, enabled by seamless technology transfer and close collaboration between site teams and bringing complex dosage form concepts to life.

Most importantly, this capability reinforces our commitment to Patient Centricity, offering innovative solutions designed with patient needs at the core.

Learn more in our press release:https://ppsazdevwebsitestg.blob.core.windows.net/public/uploads/generic_file_upload/020226164453-Piramal-Pharma-Solutions-Introduces-Tablet-in-Capsule-Capabilities.pdf

Dyno-Mill: Your Gateway to Better-Performing Formulations​① Why Dyno-Mill?​In today’s R&D environment, particle size isn...
02/02/2026

Dyno-Mill: Your Gateway to Better-Performing Formulations​

① Why Dyno-Mill?​
In today’s R&D environment, particle size isn’t just a parameter—it’s a pathway to enhanced bioavailability. The Dyno-Mill Lab Model helps formulation teams overcome solubility challenges through precise wet milling and nanosizing. From oral dosage forms to nanosuspensions, injectables, and ophthalmic products, Dyno-Mill enables smarter, more efficient formulations.​

​② How does it boost solubility?​
By reducing particle size into the submicron/nano range, Dyno-Mill dramatically increases surface area, improves dissolution rate, and enhances bioavailability—while preserving crystalline integrity.​

​③ Ideal for:​
•⁠ ⁠Poorly soluble APIs (BCS II & IV)​
•⁠ ⁠Oral & injectable nanosuspensions​
•⁠ ⁠Topical and ophthalmic dispersions​
•⁠ ⁠Parenteral systems & vaccine adjuvants

④ R&D batch flexibility​
Designed for 100 mL to 500 mL batches, it’s perfect for feasibility studies, prototypes, and optimization work with minimal API usage.​

​

We’re excited to be bringing back our Japan Technical Seminar 2026!Held alongside CPhI Japan and in collaboration with A...
02/02/2026

We’re excited to be bringing back our Japan Technical Seminar 2026!

Held alongside CPhI Japan and in collaboration with Ajinomoto Bio-Pharma Services, this year’s seminar will bring together experts for in-depth technical discussions and knowledge sharing. The seminar will feature expert perspectives on emerging technologies and development strategies, including an introduction to AJICAP®, Ajinomoto’s proprietary platform for site‑specific ADC development, followed by cocktails, dinner, and networking with industry peers.

Date: 21 April 2026
Location: The Hilton Tokyo Odaiba
Time: 5:30 PM onwards

To register your interest, please RSVP to teppei.yamaguchi@piramal.com

More details to follow. We look forward to welcoming you in Tokyo.

Sustainable development guides every decision at Piramal Pharma Solutions.From resource efficiency to community impact, ...
01/30/2026

Sustainable development guides every decision at Piramal Pharma Solutions.

From resource efficiency to community impact, we are committed to operating responsibly while creating meaningful, long-term value.

Learn how our sustainability framework integrates environmental, economic, and social priorities into our daily operations: https://www.piramalpharmasolutions.com/sustainability

Transforming a molecule into a market-ready medicine requires more than science, it demands precision, scalability, and ...
01/27/2026

Transforming a molecule into a market-ready medicine requires more than science, it demands precision, scalability, and compliance at every step.

By refining each stage, from chemical synthesis and formulation to analytical testing and scale-up, we help partners identify the most efficient, cost-effective, and sustainable ways to manufacture their therapies. Additionally, advanced analytical tools and modeling techniques allow us to monitor reactions in real time, improve batch-to-batch consistency, and accelerate time to market.

Partnering with a CDMO like Piramal Pharma Solutions provides access to global infrastructure, specialised expertise, and integrated process development services, ensuring a seamless transition from early R&D to commercial production.

Every process we design is tailored to the molecule's unique characteristics, bridging the gap between scientific discovery and successful drug manufacturing worldwide.

Head to our blog to read more: https://www.piramalpharmasolutions.com/resources/blogs/process-development-in-drug-manufacturing

The countdown is ON! Piramal Pharma Solutions is excited to be part of World ADC, London 2026.Join the conversation on A...
01/26/2026

The countdown is ON!

Piramal Pharma Solutions is excited to be part of World ADC, London 2026.

Join the conversation on ADC Scale-Up & Validation and engage with our experts as we share deep technical insight backed by proven our ADC experience.

Here’s what you can look forward to:

- Gain actionable insights from our team of experts.

- See how ADCelerate™️ drives faster, scalable, and science-backed solutions.

- Explore our end-to-end capabilities across bioconjugation, analytics, and manufacturing

- Don’t miss our session on Day One at 11:30 AM, within the Process & Analytical Development Track

We look forward to a day ofmeaningful conversations, and shared goals toward better patient outcomes.

📅 26 February
📍 London, UK
📌 Booth No. 31

At PPDS Ahmedabad, our performance speaks for itself. With a strong foundation of scientific rigor, operational excellen...
01/26/2026

At PPDS Ahmedabad, our performance speaks for itself. With a strong foundation of scientific rigor, operational excellence, and a deeply embedded compliance culture, we’ve built a track record that global innovators trust.​

​What We’ve Delivered:​

- 300+ products successfully developed — spanning the full product lifecycle, from early-phase concepts to commercial launch-ready formulations.​

​- 1290+ analytical and clinical methods developed & validated — delivering phase-appropriate, robust, and reproducible analytical solutions that stand up to regulatory expectations.​

​- 475+ clinical shipments executed flawlessly — ensuring on-time delivery with uncompromising chain-of-custody, documentation, and compliance standards.​

​- 100+ customer audits completed with excellence — consistently demonstrating maturity in operations, systems, and quality during global customer and regulatory inspections.​

​Every milestone reflects our unwavering commitment to quality, reliability, and partnership. At PPDS Ahmedabad, we don’t just execute projects—we help our customers advance with confidence.​

​ hashtag hashtag hashtag

Managing complex CDMO programs requires more than coordination it demands structure, clarity, and a framework built to a...
01/23/2026

Managing complex CDMO programs requires more than coordination it demands structure, clarity, and a framework built to align every moving part.​

​Piramal Pharma Solutions brings integrated project management, cross-functional teams, and unified governance to ensure each stage progresses with accuracy and transparency.​

Explore our latest blog to see how strong project management transforms complexity into a streamlined path from development to delivery.​
https://www.piramalpharmasolutions.com/resources/blogs/how-project-management-impacts-cdmos

Serving customers across North America, Europe, and Asia, Piramal Pharma Solutions operates a global network of advanced...
01/22/2026

Serving customers across North America, Europe, and Asia, Piramal Pharma Solutions operates a global network of advanced facilities designed to support the full drug lifecycle.

Our integrated sites bring together capabilities in drug discovery, pharmaceutical development, clinical trial supplies, and commercial manufacturing, ensuring consistency, scale, and regulatory excellence across regions.

Each facility plays a distinct role within this connected network, enabling seamless collaboration and high-quality outcomes for our customers worldwide.

Want to learn more about each site and its capabilities? Explore the Facilities page on our website! https://www.piramalpharmasolutions.com/facilities

Address

18655 Krause Street
Riverview, MI
48193

Website

Alerts

Be the first to know and let us send you an email when Piramal Pharma Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category